Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menatetrenone vs Alfacalcidol in Postmenopausal Osteoporosis
NCT00165698Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of menatetrenone in postmenopausal osteoporosis, sponsored by Eisai Co., Ltd.. Started May 2005; status: completed.
02
Drugs
menatetrenone
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00165698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165698.